|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
EP0378881B1
(en)
|
1989-01-17 |
1993-06-09 |
ENIRICERCHE S.p.A. |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
US7252829B1
(en)
*
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
US5550214A
(en)
*
|
1994-02-10 |
1996-08-27 |
Brigham And Women's Hospital |
Isolated antigenic oncogene peptide fragments and uses
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
KR100642044B1
(ko)
|
1999-03-19 |
2006-11-10 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신
|
|
EP1165796A2
(en)
|
1999-04-09 |
2002-01-02 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
AU5898400A
(en)
*
|
1999-06-29 |
2001-01-31 |
Epimmune, Inc. |
Hla binding peptides and their uses
|
|
WO2001041787A1
(en)
*
|
1999-12-10 |
2001-06-14 |
Epimmune Inc. |
INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
|
|
US20020197266A1
(en)
|
2000-02-08 |
2002-12-26 |
Waldemar Debinski |
Immunotherapy using interleukin 13 receptor subunit alpha 2
|
|
CA2400215A1
(en)
|
2000-02-23 |
2001-08-30 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
US7892559B2
(en)
|
2002-01-30 |
2011-02-22 |
Survac Aps |
Survivin-derived peptides and use thereof
|
|
JP2005526842A
(ja)
|
2002-03-22 |
2005-09-08 |
ザ ペン ステート リサーチ ファウンデーション |
癌免疫療法
|
|
CA2500715A1
(en)
|
2002-10-03 |
2004-04-15 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
WO2005076001A2
(en)
*
|
2004-02-06 |
2005-08-18 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
|
|
WO2006034334A2
(en)
|
2004-09-21 |
2006-03-30 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response
|
|
US7666622B2
(en)
|
2005-10-19 |
2010-02-23 |
Regeneron Pharmaceuticals, Inc. |
Monomeric self-associating fusion polypeptides and therapeutic uses thereof
|
|
BRPI0720280A2
(pt)
|
2006-12-11 |
2014-01-28 |
Wyeth Corp |
Métodos e composições para tratar e monitorar tratamento de desordens associadas à il-13
|
|
JP2010190572A
(ja)
|
2007-06-01 |
2010-09-02 |
Sapporo Medical Univ |
ＩＬ１３Ｒａ２に対する抗体およびこれを含む診断・治療薬
|
|
JP5191537B2
(ja)
|
2007-06-18 |
2013-05-08 |
エム・エス・ディー・オス・ベー・フェー |
ヒトのプログラムされたデスレセプターｐｄ−１に対する抗体
|
|
JP5555952B2
(ja)
|
2007-08-20 |
2014-07-23 |
オンコセラピー・サイエンス株式会社 |
Ｆｏｘｍ１ペプチドおよびこれを含む薬剤
|
|
WO2010018136A1
(en)
|
2008-08-12 |
2010-02-18 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Minigene comprising htpa signal peptide, t-cell epitopes, e. coli ltb and furin sensitive linkers
|
|
HUE065752T2
(hu)
|
2008-12-09 |
2024-06-28 |
Hoffmann La Roche |
Anti-PD-L1 antitestek és felhasználásuk T-sejt funkció elõsegítésére
|
|
US20110033389A1
(en)
*
|
2009-04-29 |
2011-02-10 |
Zhifeng Chen |
Modified antibodies for passive immunotherapy
|
|
PT2504364T
(pt)
|
2009-11-24 |
2017-11-14 |
Medimmune Ltd |
Agentes de ligação direcionados contra b7-h1
|
|
WO2011140284A2
(en)
|
2010-05-04 |
2011-11-10 |
Fred Hutchinson Cancer Research Center |
Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses
|
|
WO2012027379A2
(en)
|
2010-08-24 |
2012-03-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
|
|
EP2639299A1
(en)
|
2012-03-16 |
2013-09-18 |
Invectys |
Universal cancer peptides derived from telomerase
|
|
ES2973957T3
(es)
|
2012-03-19 |
2024-06-25 |
Stemline Therapeutics Inc |
Métodos para tratar y monitorizar el estado de un cáncer
|
|
US9428813B2
(en)
|
2012-03-26 |
2016-08-30 |
The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services |
DNA methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
|
|
SMT202100545T1
(it)
|
2012-05-16 |
2021-11-12 |
Stemline Therapeutics Inc |
Vaccini contro il cancro mirati alle cellule staminali cancerose
|
|
US20140141044A1
(en)
*
|
2012-11-12 |
2014-05-22 |
Dana-Farber Cancer Institute, Inc. |
Cord Colitis Syndrome Pathogen
|
|
KR20180049238A
(ko)
|
2012-12-05 |
2018-05-10 |
솔라 바이오사이언시즈 엘엘씨 |
단백질 발현 증진 폴리펩타이드
|
|
WO2014088432A1
(en)
|
2012-12-06 |
2014-06-12 |
Callaghan Innovation Research Limited |
Conjugate compounds
|
|
KR20160016725A
(ko)
*
|
2014-08-05 |
2016-02-15 |
주식회사 유영제약 |
암 세포에 과발현되는 IL13Rα2에 특이적으로 결합하는 키메라 항원 수용체로 변형된 T 세포
|
|
WO2016133779A1
(en)
|
2015-02-16 |
2016-08-25 |
The Trustees Of The University Of Pennsylvania |
A fully-human t cell receptor specific for the 369-377 epitope derived from the her2/neu (erbb2) receptor protein
|
|
WO2016146143A1
(en)
|
2015-03-16 |
2016-09-22 |
Amal Therapeutics Sa |
Cell penetrating peptides and complexes comprising the same
|
|
US20180078627A1
(en)
*
|
2015-03-31 |
2018-03-22 |
Agency For Science, Technology And Research |
Method for antigen loading of dendritic cells and vaccine
|
|
EP3464630A1
(en)
|
2016-05-23 |
2019-04-10 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Methods of diagnosing cancer using cancer testis antigens
|
|
IL302345B2
(en)
|
2016-10-07 |
2024-12-01 |
Enterome S A |
Immunogenic compounds for cancer therapy
|
|
CN110049774A
(zh)
|
2016-10-07 |
2019-07-23 |
恩特罗姆公司 |
肿瘤相关抗原表位的小型生物群序列变体
|
|
WO2018065625A2
(en)
|
2016-10-07 |
2018-04-12 |
Enterome |
Immunogenic compounds for cancer therapy
|
|
KR102823291B1
(ko)
|
2017-10-09 |
2025-06-19 |
엔터롬 에스.에이. |
종양-관련된 항원 에피토프의 미생물 서열 변이체
|
|
SI3773689T1
(sl)
|
2018-04-11 |
2023-02-28 |
Enterome S.A. |
Antigenski peptidi za preprečevanje in zdravljenje raka
|
|
US20210106652A1
(en)
|
2018-04-11 |
2021-04-15 |
Enterome S.A. |
Immunogenic Compounds For Treatment Of Fibrosis, Autoimmune Diseases And Inflammation
|
|
WO2021074389A1
(en)
|
2019-10-16 |
2021-04-22 |
Enterome S.A. |
Immunogenic compounds for treatment of adrenal cancer
|
|
HUE065075T2
(hu)
|
2019-11-15 |
2024-04-28 |
Enterome S A |
Antigén peptidek B-sejtes malignitás megelõzésére és kezelésére
|